Aglaia Athanassiadou

University of Patras — Greece

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index9.7kcitations65works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(18), Hemoglobinopathies and Related Disorders(12), RNA Interference and Gene Delivery(12), CRISPR and Genetic Engineering(12), Parkinson's Disease Mechanisms and Treatments(10)

Publications65 total

The β-Hemoglobinopathies as a Model for the Development of Nonviral, Episomal Vectors for Gene Therapy
Human Gene Therapy·2025
Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells
Genes·2023· 4 citedOpen Access
Lipid level alteration in human and cellular models of alpha synuclein mutations
npj Parkinson s Disease·2022· 21 citedOpen Access
USING A NONVIRAL AND NONINTEGRATING DNA VECTOR TO GENERATE SAFE CAR-T CELLS
Hematology Transfusion and Cell Therapy·2021Open Access
Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy
Human Gene Therapy·2021· 32 citedOpen Access
Genetic Complexity of the Human Genome in Health and Disease: Basic Concepts
Nonlinear Phenomena in Complex Systems·2020Open Access
Emerging patent landscape for non-viral vectors used for gene therapy
Nature Biotechnology·2020· 82 citedOpen Access
Episomal vectors based on S/MAR and the β-globin Replicator, encoding a synthetic transcriptional activator, mediate efficient γ-globin activation in haematopoietic cells
Scientific Reports·2019· 16 citedOpen Access
Efficient episomal gene transfer to human hepatic cells using the pFAR4–S/MAR vector
Molecular Biology Reports·2019· 9 cited
Improved molecular platform for the gene therapy of rare diseases by liver protein secretion
European Journal of Medical Genetics·2018· 13 cited
The β-globin Replicator greatly enhances the potential of S/MAR based episomal vectors for gene transfer into human haematopoietic progenitor cells
Scientific Reports·2017· 20 citedOpen Access
Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates
PLoS ONE·2016· 15 citedOpen Access
Motor and Nonmotor Features of Carriers of the p.A53T Alpha‐Synuclein Mutation: A Longitudinal Study
Movement Disorders·2016· 79 cited
Peripheral alpha-synuclein markers in subjects harboring the G209A mutation in the SNCA gene
University of Thessaly Institutional Repository (University of Thessaly)·2015
248. A Bona Fide Mammalian Replicator Enhances All Aspects of Episomal Gene Transfer Into Human Hematopoietic Progenitor Cells
Molecular Therapy·2015· 1 citedOpen Access
Phenotypic Spectrum of SNCA G209A Mutation Carriers for Familial Parkinson's Disease in Greece (P2.022)
Neurology·2014
Genetic assessment of familial and early‐onset Parkinson's disease in a Greek population
European Journal of Neurology·2013· 65 cited
Cytochrome P450 2C19 Polymorphism and Antiplatelet Therapy. Who Should Really be Genotyped?
Current Pharmaceutical Design·2013· 3 cited
Prasugrel Versus High Dose Clopidogrel to Overcome Early High on Clopidogrel Platelet Reactivity in Patients with ST Elevation Myocardial Infarction
Cardiovascular Drugs and Therapy·2012· 41 cited
Hematopoietic Cell Mobilization for Gene Therapy of Adult Patients with Severe Beta-Thalassemia: The Challenge of Splenectomy and the Role of Plerixafor
Blood·2011· 1 cited
page 1 of 4Next →

Frequent Co-authors

Eleana F. Stavrou(16), George M. Maniatis(6), Lambrini Psiouri(5), Nicholas Zoumbos(5), Adamantia Papachatzopoulou(5), Argyro Sgourou(5), Ioannis K. Zarkadis(5), George Kassimis(4), Adamandia Papachatzopoulou(4), Michael Antoniou(4), Aristeidis Giannakopoulos(4), Gerassimos E. Voutsinas(3), Thodoros Papapetropoulos(3), Dimitrios Alexopoulos(3), Periklis Davlouros(3), Ioanna Xanthopoulou(3), Eirini P. Papapetrou(3), Dimitra Papadimitriou(3), Alexandros Papadimitriou(3), Leonidas Stefanis(3)